Original filing (PDF)20240723095245NAL0007161827001

Alcala Pharmaceuticals, Inc.

Name: Alcala Pharmaceuticals, Inc. — Alcala Pharmaceutical, Form 5500 (2023)
Creator: Alcala Pharmaceuticals, Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Alcala Pharmaceuticals, Inc. 401(k) Profit Sharing Plan

401(k) retirement plan · Alcala Pharmaceuticals, Inc.'s Alcala Pharmaceuticals, Inc. 401(k) Profit Sharing Plan filed a Form 5500 for plan year 2023.

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

Plan identifiers

Alcala Pharmaceuticals, Inc.'s EIN is 27-2099292.

EIN 27-2099292

Plan number 001

Plan year 2023

ACK ID 20240723095245NAL0007161827001

Official Form 5500 document

Download the official 2023 Form 5500 (PDF) for Alcala Pharmaceuticals, Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2023 Form 5500 (PDF)

Plan features

Alcala Pharmaceuticals, Inc.'s plan includes profit-sharing, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ALCALA PHARMACEUTICALS, INC..

Finding similar companies…

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Helping the score